{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "18973662", "DateCompleted": {"Year": "2008", "Month": "12", "Day": "29"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "13"}, "Article": {"ArticleDate": [{"Year": "2008", "Month": "10", "Day": "30"}], "Language": ["eng"], "ELocationID": ["10.1186/1472-6882-8-59"], "Journal": {"ISSN": "1472-6882", "JournalIssue": {"Volume": "8", "PubDate": {"Year": "2008", "Month": "Oct", "Day": "30"}}, "Title": "BMC complementary and alternative medicine", "ISOAbbreviation": "BMC Complement Altern Med"}, "ArticleTitle": "Induction of apoptosis of human primary osteoclasts treated with extracts from the medicinal plant Emblica officinalis.", "Pagination": {"StartPage": "59", "MedlinePgn": "59"}, "Abstract": {"AbstractText": ["Osteoclasts (OCs) are involved in rheumatoid arthritis and in several pathologies associated with bone loss. Recent results support the concept that some medicinal plants and derived natural products are of great interest for developing therapeutic strategies against bone disorders, including rheumatoid arthritis and osteoporosis. In this study we determined whether extracts of Emblica officinalis fruits display activity of possible interest for the treatment of rheumatoid arthritis and osteoporosis by activating programmed cell death of human primary osteoclasts.", "The effects of extracts from Emblica officinalis on differentiation and survival of human primary OCs cultures obtained from peripheral blood were determined by tartrate-acid resistant acid phosphatase (TRAP)-positivity and colorimetric MTT assay. The effects of Emblica officinalis extracts on induction of OCs apoptosis were studied using TUNEL and immunocytochemical analysis of FAS receptor expression. Finally, in vitro effects of Emblica officinalis extracts on NF-kB transcription factor activity were determined by gel shift experiments.", "Extracts of Emblica officinalis were able to induce programmed cell death of mature OCs, without altering, at the concentrations employed in our study, the process of osteoclastogenesis. Emblica officinalis increased the expression levels of Fas, a critical member of the apoptotic pathway. Gel shift experiments demonstrated that Emblica officinalis extracts act by interfering with NF-kB activity, a transcription factor involved in osteoclast biology. The data obtained demonstrate that Emblica officinalis extracts selectively compete with the binding of transcription factor NF-kB to its specific target DNA sequences. This effect might explain the observed effects of Emblica officinalis on the expression levels of interleukin-6, a NF-kB specific target gene.", "Induction of apoptosis of osteoclasts could be an important strategy both in interfering with rheumatoid arthritis complications of the bone skeleton leading to joint destruction, and preventing and reducing osteoporosis. Accordingly, we suggest the application of Emblica officinalis extracts as an alternative tool for therapy applied to bone diseases."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "BioPharmaNet, ER-GenTech, Department of Biochemistry and Molecular Biology, Ferrara University, Ferrara, Italy. pnlmlt@unife.it"}], "Identifier": [], "LastName": "Penolazzi", "ForeName": "Letizia", "Initials": "L"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Lampronti", "ForeName": "Ilaria", "Initials": "I"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Borgatti", "ForeName": "Monica", "Initials": "M"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Khan", "ForeName": "Mahmud Tareq Hassan", "Initials": "MT"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Zennaro", "ForeName": "Margherita", "Initials": "M"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Piva", "ForeName": "Roberta", "Initials": "R"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Gambari", "ForeName": "Roberto", "Initials": "R"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "BMC Complement Altern Med", "NlmUniqueID": "101088661", "ISSNLinking": "1472-6882"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "DNA-Binding Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "NF-kappa B"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}], "MeshHeadingList": [{"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Bone Resorption"}, {"QualifierName": ["drug effects"], "DescriptorName": "DNA-Binding Proteins"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Immunohistochemistry"}, {"QualifierName": ["drug effects"], "DescriptorName": "NF-kappa B"}, {"QualifierName": ["drug effects"], "DescriptorName": "Osteoclasts"}, {"QualifierName": [], "DescriptorName": "Phyllanthus emblica"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Szekanecz Z, Koch AE. Macrophages and their products in rheumatoid arthritis. Curr Opin Rheumatol. 2007;19:289\u201395. doi: 10.1097/BOR.0b013e32805e87ae.", "ArticleIdList": ["10.1097/BOR.0b013e32805e87ae", "17414958"]}, {"Citation": "Hadjidakis DJ, Androulakis II. Bone remodeling. Ann N Y Acad Sci. 2006;1092:385\u201396. doi: 10.1196/annals.1365.035.", "ArticleIdList": ["10.1196/annals.1365.035", "17308163"]}, {"Citation": "Giuliani N, Morandi F, Tagliaferri S, Rizzoli V. Targeting pathways mediating bone disease. Curr Pharm Biotechnol. 2006;7:423\u20139. doi: 10.2174/138920106779116955.", "ArticleIdList": ["10.2174/138920106779116955", "17168658"]}, {"Citation": "Blair HC, Zaidi M. Osteoclastic differentiation and function regulated by old and new pathways. Rev Endocr Metab Disord. 2006;7:23\u201332. doi: 10.1007/s11154-006-9010-4.", "ArticleIdList": ["10.1007/s11154-006-9010-4", "17115268"]}, {"Citation": "Ochi S, Shinohara M, Sato K, Gober HJ, Koga T, Kodama T, Takai T, Miyasaka N, Takayanagi H. Pathological role of osteoclast costimulation in arthritis-induced bone loss. Proc Natl Acad Sci USA. 2007;104:11394\u201311399. doi: 10.1073/pnas.0701971104.", "ArticleIdList": ["10.1073/pnas.0701971104", "PMC2040909", "17592115"]}, {"Citation": "Schett G. Cells of the synovium in rheumatoid arthritis. Osteoclasts. Arthritis Res Ther. 2007;9:203. doi: 10.1186/ar2110.", "ArticleIdList": ["10.1186/ar2110", "PMC1860063", "17316459"]}, {"Citation": "Haynes DR. Emerging and future therapies for the treatment of bone loss associated with chronic inflammation. Inflammopharmacology. 2006;14:193\u20137. doi: 10.1007/s10787-006-0006-1.", "ArticleIdList": ["10.1007/s10787-006-0006-1", "17093901"]}, {"Citation": "Tremoulet AH, Albani S. Novel therapies for rheumatoid arthritis. Expert Opin Investig Drugs. 2006;15:1427\u201341. doi: 10.1517/13543784.15.11.1427.", "ArticleIdList": ["10.1517/13543784.15.11.1427", "17040201"]}, {"Citation": "Boyce BF, Schwarz EM, Xing L. Osteoclast precursors: cytokine-stimulated immunomodulators of inflammatory bone disease. Curr Opin Rheumatol. 2006;18:427\u201332. doi: 10.1097/01.bor.0000231913.32364.32.", "ArticleIdList": ["10.1097/01.bor.0000231913.32364.32", "16763465"]}, {"Citation": "Sato K, Takayanagi H. Osteoclasts, rheumatoid arthritis, and osteoimmunology. Curr Opin Rheumatol. 2006;18:419\u201326. doi: 10.1097/01.bor.0000231912.24740.a5.", "ArticleIdList": ["10.1097/01.bor.0000231912.24740.a5", "16763464"]}, {"Citation": "Teitelbaum SL. Osteoclasts; culprits in inflammatory osteolysis. Arthritis Res Ther. 2006;8:201. doi: 10.1186/ar1857.", "ArticleIdList": ["10.1186/ar1857", "PMC1526550", "16356195"]}, {"Citation": "Kim KW, Cho ML, Lee SH, Oh HJ, Kang CM, Ju JH, Min SY, Cho YG, Park SH, Kim HY. Human rheumatoid synovial fibroblasts promote osteoclastogenic activity by activating RANKL via TLR-2 and TLR-4 activation. Immunol Lett. 2007;110:54\u201364. doi: 10.1016/j.imlet.2007.03.004.", "ArticleIdList": ["10.1016/j.imlet.2007.03.004", "17467812"]}, {"Citation": "Colucci S, Brunetti G, Cantatore FP, Oranger A, Mori G, Quarta L, Cirulli N, Mancini L, Corrado A, Grassi FR, Grano M. Lymphocytes and synovial fluid fibroblasts support osteoclastogenesis through RANKL, TNFalpha, and IL-7 in an in vitro model derived from human psoriatic arthritis. J Pathol. 2007;212:47\u201355. doi: 10.1002/path.2153.", "ArticleIdList": ["10.1002/path.2153", "17370327"]}, {"Citation": "Tanishima S, Kishimoto Y, Fukata S, Mizumura H, Hagino H, Teshima R. Minodronic acid influences receptor activator of nuclear factor kB ligand expression and suppresses bone resorption by osteoclasts in rats with collagen-induced arthritis. Mod Rheumatol. 2007;17:198\u2013205. doi: 10.1007/s10165-007-0566-y.", "ArticleIdList": ["10.1007/s10165-007-0566-y", "17564774"]}, {"Citation": "Kitahara K, Kawai S. Cyclosporine and tacrolimus for the treatment of rheumatoid arthritis. Curr Opin Rheumatol. 2007;19:238\u201345. doi: 10.1097/BOR.0b013e328099af80.", "ArticleIdList": ["10.1097/BOR.0b013e328099af80", "17414949"]}, {"Citation": "Gillespie MT. Impact of cytokines and T lymphocytes upon osteoclast differentiation and function. Arthritis Res Ther. 2007;9:103. doi: 10.1186/ar2141.", "ArticleIdList": ["10.1186/ar2141", "PMC1906805", "17381830"]}, {"Citation": "Suematsu A, Tajiri Y, Nakashima T, Taka J, Ochi S, Oda H, Nakamura K, Tanaka S, Takayanagi H. Scientific basis for the efficacy of combined use of antirheumatic drugs against bone destruction in rheumatoid arthritis. Mod Rheumatol. 2007;17:17\u201323. doi: 10.1007/s10165-006-0531-1.", "ArticleIdList": ["10.1007/s10165-006-0531-1", "17278017"]}, {"Citation": "Shu G, Yamamoto K, Nagashima M. Differences in osteoclast formation between proximal and distal tibial osteoporosis in rats with adjuvant arthritis: inhibitory effects of bisphosphonates on osteoclasts. Mod Rheumatol. 2006;16:343\u20139. doi: 10.1007/s10165-006-0515-1.", "ArticleIdList": ["10.1007/s10165-006-0515-1", "17164994"]}, {"Citation": "Haynes DR. Emerging and future therapies for the treatment of bone loss associated with chronic inflammation. Inflammopharmacology. 2006;14:193\u20137. doi: 10.1007/s10787-006-0006-1.", "ArticleIdList": ["10.1007/s10787-006-0006-1", "17093901"]}, {"Citation": "Verdrengh M, Carlsten H, Ohlsson C, Tarkowski A. Addition of bisphosphonate to antibiotic and anti-inflammatory treatment reduces bone resorption in experimental Staphylococcus aureus-induced arthritis. J Orthop Res. 2007;25:304\u201310. doi: 10.1002/jor.20317.", "ArticleIdList": ["10.1002/jor.20317", "17089391"]}, {"Citation": "Croom KF, Scott LJ. Intravenous ibandronate: in the treatment of osteoporosis. Drugs. 2006;66:1593\u2013601. doi: 10.2165/00003495-200666120-00005.", "ArticleIdList": ["10.2165/00003495-200666120-00005", "16956306"]}, {"Citation": "Chapurlat RD, Delmas PD. Drug insight: Bisphosphonates for postmenopausal osteoporosis. Nat Clin Pract Endocrinol Metab. 2006;2:211\u20139. doi: 10.1038/ncpendmet0121.", "ArticleIdList": ["10.1038/ncpendmet0121", "16932286"]}, {"Citation": "Manette C, Collette J, Sarlet N, Tancredi A, Zegels B, Reginster JY. Comprehensive therapy in osteoporosis using a single drug: from ADFR to strontium ranelate. Curr Med Chem. 2006;13:1585\u201390. doi: 10.2174/092986706777442057.", "ArticleIdList": ["10.2174/092986706777442057", "16787205"]}, {"Citation": "Cicek M, Oursler MJ. Breast cancer bone metastasis and current small therapeutics. Cancer Metastasis Rev. 2006;25:635\u201344. doi: 10.1007/s10555-006-9035-x.", "ArticleIdList": ["10.1007/s10555-006-9035-x", "17160709"]}, {"Citation": "Lipton A. Future treatment of bone metastases. Clin Cancer Res. 2006;12:6305s\u20136308s. doi: 10.1158/1078-0432.CCR-06-1157.", "ArticleIdList": ["10.1158/1078-0432.CCR-06-1157", "17062719"]}, {"Citation": "Bagi CM. Targeting of therapeutic agents to bone to treat metastatic cancer. Adv Drug Deliv Rev. 2005;57:995\u20131010. doi: 10.1016/j.addr.2004.12.014.", "ArticleIdList": ["10.1016/j.addr.2004.12.014", "15876400"]}, {"Citation": "Kanakis I, Kousidou OCh, Karamanos NK. In vitro and in vivo antiresorptive effects of bisphosphonates in metastatic bone disease. In Vivo. 2005;19:311\u20138.", "ArticleIdList": ["15796191"]}, {"Citation": "Putnam SE, Scutt AM, Bicknell K, Priestley CM, Williamson EM. Natural products as alternative treatments for metabolic bone disorders and for maintenance of bone health. Phytother Res. 2007;21:99\u2013112. doi: 10.1002/ptr.2030.", "ArticleIdList": ["10.1002/ptr.2030", "17106868"]}, {"Citation": "New SA. Intake of fruit and vegetables: implications for bone health. Proc Nutr Soc. 2003;62:889\u201399.", "ArticleIdList": ["15018489"]}, {"Citation": "Hidaka S, Okamoto Y, Yamada Y, Kon Y, Kimura TA. Japanese herbal medicine, Chujo-to, has a beneficial effect on osteoporosis in rats. Phytother Res. 1999;13:14\u20139. doi: 10.1002/(SICI)1099-1573(199902)13:1<14::AID-PTR375>3.0.CO;2-V.", "ArticleIdList": ["10.1002/(SICI)1099-1573(199902)13:1<14::AID-PTR375>3.0.CO;2-V", "10189944"]}, {"Citation": "Funk JL, Oyarzo JN, Frye JB, Chen G, Lantz RC, Jolad SD, Solyom AM, Timmermann BN. Turmeric extracts containing curcuminoids prevent experimental rheumatoid arthritis. J Nat Prod. 2006;69:351\u20135. doi: 10.1021/np050327j.", "ArticleIdList": ["10.1021/np050327j", "PMC2533857", "16562833"]}, {"Citation": "Ramprasath VR, Shanthi P, Sachdanandam P. Curative effect of Semecarpus anacardium Linn. nut milk extract against adjuvant arthritis \u2013 with special reference to bone metabolism. Chem Biol Interact. 2006;160:183\u201392. doi: 10.1016/j.cbi.2005.11.009.", "ArticleIdList": ["10.1016/j.cbi.2005.11.009", "16513099"]}, {"Citation": "Sohail MT, Chaudhry MI, Usman MK, Mian T, Ishaq MN. Efficacy and tolerance of atrisin in degenerative and inflammatory joint disorders. Phytother Res. 2005;19:365\u20138. doi: 10.1002/ptr.1680.", "ArticleIdList": ["10.1002/ptr.1680", "16041739"]}, {"Citation": "Yin J, Tezuka Y, Kouda K, Le Tran Q, Miyahara T, Chen Y, Kadota S. Antiosteporotic activity of the water extract of Dioscorea spongiosa . Biol Pharm Bull. 2004;27:583\u2013586. doi: 10.1248/bpb.27.583.", "ArticleIdList": ["10.1248/bpb.27.583", "15056872"]}, {"Citation": "Wang D, Li F, Jiang Z. Osteoblastic proliferation stimulating activity of Psoralea corylifollia extracts and two of its flavonoids. Planta Med. 2001;67:748\u2013749.", "ArticleIdList": ["11731919"]}, {"Citation": "Meng F, Xiong Z, Sun Y, Li F. Coumarins from Cidium monnieri (L.) and their proliferation stimulating activity on osteoblast-like UMR106 cells. Pharmazie. 2004;59:643\u2013645.", "ArticleIdList": ["15378857"]}, {"Citation": "Anila L, Vijayalakshmi NR. Flavonoids from Emblica officinalis and Mangifera indica, effectiveness for dyslipidemia. J Ethnopharmacol. 2002;79:81\u201387. doi: 10.1016/S0378-8741(01)00361-0.", "ArticleIdList": ["10.1016/S0378-8741(01)00361-0", "11744299"]}, {"Citation": "Thakur CP, Mandal K. Effect of Emblica officinalis on cholesterol-induced atherosclerosis in rabbits Indian. J Med Res. 1984;79:142\u2013146.", "ArticleIdList": ["6724650"]}, {"Citation": "Bhattacharya A, Kumar M, Ghosal S, Bhattacharya SK. Effect of bioactive tannoid principles of Emblica officinalis on iron-indued hepatic toxicity in rats. Phytomedicine. 2000;7:173\u2013175.", "ArticleIdList": ["10839222"]}, {"Citation": "Ahmad I, Mehmood Z, Mohammad F. Screening of some Indian medicinal plants for their antimicrobial properties. J Ethnopharmacol. 1998;62:183\u201393. doi: 10.1016/S0378-8741(98)00055-5.", "ArticleIdList": ["10.1016/S0378-8741(98)00055-5", "9741890"]}, {"Citation": "Asmawi MZ, Kankaanranta H, Moilanen E, Vapaatalo H. Anti-inflammatory activities of Emblica officinalis Gaertn leaf extracts. J Pharm Pharmacol. 1993;45:581\u2013584.", "ArticleIdList": ["7689650"]}, {"Citation": "Jeena KJ, Kuttan G, Kuttan R. Antitumor activity of Emblica officinalis. J of Ethnoph. 2001;75:65\u201369. doi: 10.1016/S0378-8741(00)00378-0.", "ArticleIdList": ["10.1016/S0378-8741(00)00378-0", "11297836"]}, {"Citation": "Sancheti G, Jindal A, Kumari R, Goyal PK. Chemopreventive action of Emblica officinalis on skin carcinogenesis in mice. Asian Pac J Cancer Prev. 2005;6:197\u2013201.", "ArticleIdList": ["16101333"]}, {"Citation": "Sultana S, Ahmad S, Khan N, Jahangir T. Effect of Emblica officinalis (Gaertn) on CCl4 induced hepatic toxicity and DNA synthesis in Wistar rats. Indian J Exp Biol. 2005;43:430\u20136.", "ArticleIdList": ["15900908"]}, {"Citation": "Scartezzini P, Antognoni F, Raggi MA, Poli F, Sabbioni C. Vitamin C content and antioxidant activity of the fruit and of the Ayurvedic preparation of Emblica officinalis Gaertn. J Ethnopharmacology. 2006;104:113\u20138. doi: 10.1016/j.jep.2005.08.065.", "ArticleIdList": ["10.1016/j.jep.2005.08.065", "16226416"]}, {"Citation": "Penolazzi L, Lambertini E, Borgatti M, Piva R, Cozzani M, Giovannini I, Naccari R, Siciliani G, Gambari R. Decoy oligodeoxynucleotides targeting NF-kappaB transcription factors: induction of apoptosis in human primary osteoclasts. Biochem Pharmacol. 2003;66:1189\u201398. doi: 10.1016/S0006-2952(03)00470-2.", "ArticleIdList": ["10.1016/S0006-2952(03)00470-2", "14505798"]}, {"Citation": "Piva R, Penolazzi L, Lambertini E, Giordano S, Gambari R. Induction of apoptosis of human primary osteoclasts treated with a transcription factor decoy mimicking a promoter region of estrogen receptor alpha. Apoptosis. 2005;10:1079\u201394. doi: 10.1007/s10495-005-0618-8.", "ArticleIdList": ["10.1007/s10495-005-0618-8", "16151641"]}, {"Citation": "Borgatti M, Lampronti I, Romanelli A, Pedone C, Saviano M, Bianchi N, Mischiati C, Gambari R. Transcription factor decoy molecules based on a peptide nucleic acid (PNA)-DNA chimera mimicking Sp1 binding sites. J Biol Chem. 2003;278:7500\u20139. doi: 10.1074/jbc.M206780200.", "ArticleIdList": ["10.1074/jbc.M206780200", "12446679"]}, {"Citation": "Piva R, Penolazzi L, Zennaro M, Bianchini E, Magri E, Borgatti M, Lampronti I, Lambertini E, Tavanti E, Gambari R. Induction of apoptosis of osteoclasts by targeting transcription factors with decoy molecules. Ann N Y Acad Sci. 2006;1091:509\u201316. doi: 10.1196/annals.1378.092.", "ArticleIdList": ["10.1196/annals.1378.092", "17341640"]}, {"Citation": "Park BK, Zhang H, Zeng Q, Dai J, Keller ET, Giordano T, Gu K, Shah V, Pei L, Zarbo RJ, McCauley L, Shi S, Chen S, Wang CY. NF-kappaB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF. Nat Med. 2007;13:62\u20139. doi: 10.1038/nm1519.", "ArticleIdList": ["10.1038/nm1519", "17159986"]}, {"Citation": "Yamashita T, Yao Z, Li F, Zhang Q, Badell IR, Schwarz EM, Takeshita S, Wagner EF, Noda M, Matsuo K, Xing L, Boyce BF. NF-{kappa}B p50 and p52 Regulate Receptor Activator of NF-{kappa}B Ligand (RANKL) and Tumor Necrosis Factor-induced Osteoclast Precursor Differentiation by Activating c-Fos and NFATc1. J Biol Chem. 2007;282:18245\u201353. doi: 10.1074/jbc.M610701200.", "ArticleIdList": ["10.1074/jbc.M610701200", "17485464"]}, {"Citation": "Matsuzaki K, Katayama K, Takahashi Y, Nakamura I, Udagawa N, Tsurukai T, Nishinakamura R, Toyama Y, Yabe Y, Hori M, Takahashi N, Suda T. Human osteoclast-like cells are formed from peripheral blood mononuclear cells in a coculture with SaOS-2 cells transfected with the parathyroid hormone (PTH)/PTH-related protein receptor gene. Endocrinology. 1999;140:925\u201332. doi: 10.1210/en.140.2.925.", "ArticleIdList": ["10.1210/en.140.2.925", "9927325"]}, {"Citation": "Villanova I, Townsend PA, Uhlmann E, Knolle J, Peyman A, Amling M, Baron R, Horton MA, Teti A. Oligodeoxynucleotide targeted to the alphav gene inhibits alphav integrin synthesis, impairs osteoclast function, and activates intracellular signals to apoptosis. J Bone Miner Res. 1999;14:1867\u201379. doi: 10.1359/jbmr.1999.14.11.1867.", "ArticleIdList": ["10.1359/jbmr.1999.14.11.1867", "10571687"]}, {"Citation": "Khan MTH, Lampronti I, Martello D, Bianchi N, Jabbar S, Choudhuri SMK, Datta BK, Gambari R. Identification of pyrogallol as an antiproliferative compound present in extracts from the medicinal plant Emblica Officinalis: effects on in vitro cell growth of human tumor cell lines. Int J Oncol. 2002;20:187\u2013192.", "ArticleIdList": ["12063567"]}, {"Citation": "Lampronti I, Martello D, Bianchi N, Borgatti M, Lambertini E, Piva R, Jabbar S, Shahabuddin Kabir Choudhuri M, Tareq Hassan Khan M, Gambari R. In vitro antiproliferative effects on human tumor cell lines of extracts from the Bangladeshi medicinal plant Aegle marmelos Correa. Phytomedicine. 2003;10:300\u2013308. doi: 10.1078/094471103322004794.", "ArticleIdList": ["10.1078/094471103322004794", "12809360"]}, {"Citation": "Denizot F, Lang RJ. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. Immunol Meth. 1986;22:271\u2013277. doi: 10.1016/0022-1759(86)90368-6.", "ArticleIdList": ["10.1016/0022-1759(86)90368-6", "3486233"]}, {"Citation": "Lampronti I, Khan MTH, Borgatti M, Bianchi N, Gambari R. Inhibitory effects of Bangladeshi medicinal plant extracts on interaction teween transcription factors and target DNA sequences. Evidence-based Complementary and Alternative Medicine. 2007.", "ArticleIdList": ["PMC2529391", "18830455"]}, {"Citation": "Pritts T, Hungness E, Wang Q, Robb B, Hershko D, Hasselgren PO. Mucosal and enterocyte IL-6 production during sepsis and endotoxemia \u2013 role of transcription factors and regulation by the stress response. Am J Surg. 2002;183:372\u201383. doi: 10.1016/S0002-9610(02)00812-7.", "ArticleIdList": ["10.1016/S0002-9610(02)00812-7", "11975924"]}, {"Citation": "Domingo-Domenech J, Oliva C, Rovira A, Codony-Servat J, Bosch M, Filella X, Montagut C, Tapia M, Campas C, Dang L, Rolfe M, Ross JS, Gascon P, Albanell J, Mellado B. Interleukin 6, a nuclear factor-kappaB target, predicts resistance to docetaxel in hormone-independent prostate cancer and nuclear factor-kappaB inhibition by PS-1145 enhances docetaxel antitumor activity. Clin Cancer Res. 2006;12:5578\u201386. doi: 10.1158/1078-0432.CCR-05-2767.", "ArticleIdList": ["10.1158/1078-0432.CCR-05-2767", "17000695"]}, {"Citation": "Ameye LG, Chee WS. Osteoarthritis and nutrition. From nutraceuticals to functional foods: a systematic review of the scientific evidence. Arthritis Res Ther. 2006;8:R127. doi: 10.1186/ar2016.", "ArticleIdList": ["10.1186/ar2016", "PMC1779427", "16859534"]}, {"Citation": "Idris A, Mrak E, Greig I, Guidobono F, Ralston SH, van't Hof R. ABD56 causes osteoclast apoptosis by inhibiting the NFkappaB and ERK pathways. Biochem Biophys Res Commun. 2008;371:94\u20138. doi: 10.1016/j.bbrc.2008.04.014.", "ArticleIdList": ["10.1016/j.bbrc.2008.04.014", "18413146"]}, {"Citation": "Uchiyama S, Yamaguchi M. Genistein and zinc synergistically stimulate apoptotic cell death and suppress RANKL signaling-related gene expression in osteoclastic cells. J Cell Biochem. 2007;101:529\u201342. doi: 10.1002/jcb.21208.", "ArticleIdList": ["10.1002/jcb.21208", "17295206"]}, {"Citation": "Do SH, Lee JW, Jeong WI, Chung JY, Park SJ, Hong IH, Jeon SK, Lee IS, Jeong KS. Bone-protecting effect of Rubus coreanus by dual regulation of osteoblasts and osteoclasts. Menopause. 2008;15:676\u201383.", "ArticleIdList": ["18709701"]}, {"Citation": "Faloni AP, Sasso-Cerri E, Katchburian E, Cerri PS. Decrease in the number and apoptosis of alveolar bone osteoclasts in estrogen-treated rats. J Periodontal Res. 2007;42:193\u2013201. doi: 10.1111/j.1600-0765.2006.00932.x.", "ArticleIdList": ["10.1111/j.1600-0765.2006.00932.x", "17451538"]}, {"Citation": "Penolazzi L, Magri E, Lambertini E, Bianchini E, Piva R, Gambari R. \"In vivo\" local transfection of a cis element decoy mimicking an estrogen receptor alpha gene promoter region induces apoptosis of osteoclasts following application of orthodontic forces to rat teeth. Apoptosis. 2006;11:1653\u20136. doi: 10.1007/s10495-006-8763-2.", "ArticleIdList": ["10.1007/s10495-006-8763-2", "16738804"]}]}], "History": [{"Year": "2008", "Month": "6", "Day": "20"}, {"Year": "2008", "Month": "10", "Day": "30"}, {"Year": "2008", "Month": "11", "Day": "1", "Hour": "9", "Minute": "0"}, {"Year": "2008", "Month": "12", "Day": "30", "Hour": "9", "Minute": "0"}, {"Year": "2008", "Month": "11", "Day": "1", "Hour": "9", "Minute": "0"}, {"Year": "2008", "Month": "10", "Day": "30"}], "PublicationStatus": "epublish", "ArticleIdList": ["18973662", "PMC2587459", "10.1186/1472-6882-8-59", "1472-6882-8-59"]}}], "PubmedBookArticle": []}